Drug Development

icon_globe Committee Site     icom_facebook  Facebook Page


In vivo imaging in the 21st century is increasingly being performed with significant industrial collaborations between Pharmaceutical companies and academic and healthcare providers. This is a mutually beneficial situation which can enable in vivo imaging in ways previously unimaginable. The Drug Development Interest Group is a springboard for those of you interested in engaging and finding out more about these activities. The field is multidisciplinary in nature, covering a gamut of activities including synthetic and medicinal chemistry, biology, pharmacology, pharmacokinetics/dynamics, clinical sciences, technology and instrumentation, mathematical modelling and physics.

Committee Chairpersons

Chair & Scientific Programme Representative

J. Vercouillie (France)

Vice Chair & ESMIT Representative

W. Deuther-Conrad (Germany)

Committee Members


G. Smith (United Kingdom)

Scientific Programme Representative

L. Zimmer (France)

Guideline Representative

A. Kirjavainen (Finland)

Website Representative& Communication, Press & PR Representative

L. Aloj (United Kingdom)

Senior Advisor

A. Gee (United Kingdom)

Back to top